Abstract
BackgroundPulmonary fibrosis, either idiopathic or secondary to diseases such as systemic sclerosis, is a devastating and life threatening disorder for which effective treatment is still lacking. The bleomycin-induced pulmonary fibrosis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have